recombinant ADAM-10 inhibitor (Biozyme)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant ADAM-10 inhibitor (Biozyme)
Drug Alias NameKuzbanian
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 10 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 10
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioZyme Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioZyme Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A